Old Web
English
Sign In
Acemap
>
authorDetail
>
John P. Hanrahan
John P. Hanrahan
Ironwood Pharmaceuticals
Blood pressure
Placebo
Internal medicine
Pharmacodynamics
Medicine
4
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized, Placebo‐Controlled, Multiple‐Ascending‐Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects
2018
Clinical pharmacology in drug development
John P. Hanrahan
James Wakefield
Phebe Wilson
Marina Mihova
Jennifer Chickering
Dennis Ruff
Michael Hall
G. Todd Milne
Mark G. Currie
Albert T. Profy
Show All
Source
Cite
Save
Citations (15)
Rapid Dose Escalation Study of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in Patients with Diabetes and Hypertension
2018
Diabetes
John P. Hanrahan
James Wakefield
Phebe Wilson
Daniel P. Zimmer
Marina Mihova
Jennifer Chickering
Dennis Ruff
Michael Hall
Mark G. Currie
G. Todd Milne
Albert T. Profy
Show All
Source
Cite
Save
Citations (2)
Abstract P493: Multiple-ascending-dose Study of IW-1973, a Soluble Guanylate Cyclase Stimulator
2017
Hypertension
John P. Hanrahan
James Wakefield
Phebe Wilson
Marina Mihova
Jennifer Chickering
Dennis Ruff
Michael Hall
Todd Milne
Mark G. Currie
Albert T. Profy
Show All
Source
Cite
Save
Citations (2)
FIRST-IN-HUMAN SINGLE-ASCENDING-DOSE STUDY OF IW-1973, A NEW SOLUBLE GUANYLATE CYCLASE STIMULATOR
2016
Journal of the American College of Cardiology
John P. Hanrahan
Albert T. Profy
B. Joseph Lavins
Dennis Ruff
Gabrielle Poirier
James Wakefield
Phebe Wilson
Michael Hall
Mark G. Currie
Show All
Source
Cite
Save
Citations (3)
1